Protein A Resins Market 2018 Prominent Players - Agarose Bead Technologies (ABT), Bio-Rad Laboratories, Danaher Corporation, EMD Millipore, Expedeon, GE Healthcare, GenScript Corporation, Novasep, Repligen, Sigma-Aldrich Corporation, Takara Bio, Thermo Fi
Protein A Resins Market size is set to exceed USD 900 million by 2024; according to a new research report by Global Market Insights.
(EMAILWIRE.COM, August 14, 2018 ) Protein A Resins Market to exceed USD 900 Million by 2024 as per a new research report.
Rising incidences of chronic diseases coupled with increasing demand for monoclonal antibodies and biosimilars from end-user industries will drive protein A resins market. Growing demand for biosimilars, increasing research activities pertaining to monoclonal antibodies and development of cost-effective protein A resin will favor business growth.
Growing therapeutic application of monoclonal antibodies due to high resolution has stimulated rise in its demand. Favorable government policies for biosimilar production and technological advancements in protein purification and extraction techniques will positively impact protein A resins market. High selectivity along with precision in immunoprecipitation and antibody purification processes will drive product demand over the forecast timeframe. Moreover, presence of other alternative methods for monoclonal antibody purification may hamper protein A resins market growth over the coming years.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1146
Natural protein A resin market should grow at lucrative rate due to high antibody selectivity, ease of operation, enhanced antibody purification and yield. Antibody purification segment will witness significant growth during the forecast period owing to rising demand for monoclonal antibodies for treating cancer and other chronic diseases. Multifarious benefits delivered by protein A resins during antibody purification and immunoprecipitation processes will positively impact industry growth.
Agarose based matrix will witness considerable growth over the forecast period. Enhanced ligand binding ability of agarose coupled with high specificity will drive agarose matrix market over the forecast timeframe.
Biopharmaceutical segment will witness lucrative growth during the forecast period due to growing demand for recombinant and monoclonal antibodies. Several therapeutic applications of monoclonal antibodies including cancer treatment will drive industry growth.
U.S. protein A resins market should grow at a significant growth rate over the forecast period. Rise in number of contract research organizations, growing investment in monoclonal antibodies research and favorable regulatory scenario will drive the regional industry revenue share.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1146
Introduction of healthcare reforms, rising prevalence of chronic diseases, healthcare infrastructure development and growing demand for monoclonal antibodies and biosimilars will drive Japan market.
Increasing funding received for monoclonal antibody development research should drive Indian protein A resins market. Spain will be driven by growing demand for biosimilars and increasing investment in biosimilar development research.
Key industry players include, Merck Millipore (EMD Millipore), Purolite Life Sciences, Repligen, GE Healthcare, GenScript, Thermo Fisher Scientific, Tosoh Bioscience, Danaher, Novasep, Expedeon, Bio-Rad Laboratories, Sigma-Aldrich, Agarose Bead Technologies and Takara Bio. Industry participants are consolidating their market position by increasing their focus on research activities to develop cost effective protein A resins to satisfy growing demand.
Rising incidences of chronic diseases coupled with increasing demand for monoclonal antibodies and biosimilars from end-user industries will drive protein A resins market. Growing demand for biosimilars, increasing research activities pertaining to monoclonal antibodies and development of cost-effective protein A resin will favor business growth.
Growing therapeutic application of monoclonal antibodies due to high resolution has stimulated rise in its demand. Favorable government policies for biosimilar production and technological advancements in protein purification and extraction techniques will positively impact protein A resins market. High selectivity along with precision in immunoprecipitation and antibody purification processes will drive product demand over the forecast timeframe. Moreover, presence of other alternative methods for monoclonal antibody purification may hamper protein A resins market growth over the coming years.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1146
Natural protein A resin market should grow at lucrative rate due to high antibody selectivity, ease of operation, enhanced antibody purification and yield. Antibody purification segment will witness significant growth during the forecast period owing to rising demand for monoclonal antibodies for treating cancer and other chronic diseases. Multifarious benefits delivered by protein A resins during antibody purification and immunoprecipitation processes will positively impact industry growth.
Agarose based matrix will witness considerable growth over the forecast period. Enhanced ligand binding ability of agarose coupled with high specificity will drive agarose matrix market over the forecast timeframe.
Biopharmaceutical segment will witness lucrative growth during the forecast period due to growing demand for recombinant and monoclonal antibodies. Several therapeutic applications of monoclonal antibodies including cancer treatment will drive industry growth.
U.S. protein A resins market should grow at a significant growth rate over the forecast period. Rise in number of contract research organizations, growing investment in monoclonal antibodies research and favorable regulatory scenario will drive the regional industry revenue share.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1146
Introduction of healthcare reforms, rising prevalence of chronic diseases, healthcare infrastructure development and growing demand for monoclonal antibodies and biosimilars will drive Japan market.
Increasing funding received for monoclonal antibody development research should drive Indian protein A resins market. Spain will be driven by growing demand for biosimilars and increasing investment in biosimilar development research.
Key industry players include, Merck Millipore (EMD Millipore), Purolite Life Sciences, Repligen, GE Healthcare, GenScript, Thermo Fisher Scientific, Tosoh Bioscience, Danaher, Novasep, Expedeon, Bio-Rad Laboratories, Sigma-Aldrich, Agarose Bead Technologies and Takara Bio. Industry participants are consolidating their market position by increasing their focus on research activities to develop cost effective protein A resins to satisfy growing demand.
Contact Information:
Global Market Insights, Inc.
Arun Hegde
Tel: 1-888-689-0688
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Global Market Insights, Inc.
Arun Hegde
Tel: 1-888-689-0688
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results